Loading clinical trials...
Loading clinical trials...
ADOPT: Adaptive Organoid-Based Precision Therapy Study in Pancreatic Cancer - A Prospective Single-Arm Phase II Trial
Conditions
Interventions
Cobimetinib
Ponatinib
+8 more
Locations
1
Canada
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Start Date
February 17, 2025
Primary Completion Date
February 17, 2028
Completion Date
February 17, 2028
Last Updated
February 18, 2025
NCT04657068
NCT04900818
NCT05004116
NCT06440005
NCT07246954
NCT06242470
Lead Sponsor
University Health Network, Toronto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions